Cargando…

Serum lipopolysaccharide neutralizing capacity in ischemic stroke

INTRODUCTION: Periodontitis is associated with increased serum lipopolysaccharide (LPS) activity, which may be one mechanism linking periodontitis with the risk of cardiovascular diseases. As LPS-carrying proteins including lipoproteins modify LPS-activity, we investigated the determinants of serum...

Descripción completa

Detalles Bibliográficos
Autores principales: Leskelä, Jaakko, Pietiäinen, Milla, Safer, Anton, Lehto, Markku, Metso, Jari, Malle, Ernst, Buggle, Florian, Becher, Heiko, Sundvall, Jouko, Grau, Armin J., Pussinen, Pirkko J., Palm, Frederick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034831/
https://www.ncbi.nlm.nih.gov/pubmed/32084157
http://dx.doi.org/10.1371/journal.pone.0228806
_version_ 1783499951323480064
author Leskelä, Jaakko
Pietiäinen, Milla
Safer, Anton
Lehto, Markku
Metso, Jari
Malle, Ernst
Buggle, Florian
Becher, Heiko
Sundvall, Jouko
Grau, Armin J.
Pussinen, Pirkko J.
Palm, Frederick
author_facet Leskelä, Jaakko
Pietiäinen, Milla
Safer, Anton
Lehto, Markku
Metso, Jari
Malle, Ernst
Buggle, Florian
Becher, Heiko
Sundvall, Jouko
Grau, Armin J.
Pussinen, Pirkko J.
Palm, Frederick
author_sort Leskelä, Jaakko
collection PubMed
description INTRODUCTION: Periodontitis is associated with increased serum lipopolysaccharide (LPS) activity, which may be one mechanism linking periodontitis with the risk of cardiovascular diseases. As LPS-carrying proteins including lipoproteins modify LPS-activity, we investigated the determinants of serum LPS-neutralizing capacity (LPS-NC) in ischemic stroke. The association of LPS-NC and Aggregatibacter actinomycetemcomitans, a major microbial biomarker in periodontitis, was also investigated. MATERIALS AND METHODS: The assay to measure LPS-NC was set up by spiking serum samples with E. coli LPS. The LPS-NC, LPS-binding protein (LBP), soluble CD14 (sCD14), lipoprotein profiles, apo(lipoprotein) A-I, apoB, and phospholipid transfer protein (PLTP) activity, were determined in 98 ischemic stroke patients and 100 age- and sex-matched controls. Serum and saliva immune response to A. actinomycetemcomitans, its concentration in saliva, and serotype-distribution were examined. RESULTS: LPS-NC values ranged between 51–83% in the whole population. Although several of the LPS-NC determinants differed significantly between cases and controls (PLTP, sCD14, apoA-I, HDL-cholesterol), the levels did not (p = 0.056). The main determinants of LPS-NC were i) triglycerides (β = -0.68, p<0.001), and ii) HDL cholesterol (0.260, <0.001), LDL cholesterol (-0.265, <0.001), PLTP (-0.196, 0.011), and IgG against A. actinomycetemcomitans (0.174, 0.011). Saliva A. actinomycetemcomitans concentration was higher [log mean (95% CI), 4.39 (2.35–8.19) vs. 10.7 (5.45–21) genomes/ml, p = 0.023) and serotype D more frequent (4 vs. 0%, p = 0.043) in cases than controls. Serotypeablity or serotypes did not, however, relate to the LPS-NC. CONCLUSION: Serum LPS-NC comprised low PLTP-activity, triglyceride and LDL cholesterol concentrations, as well as high HDL cholesterol and IgG against A. actinomycetemcomitans. The present findings let us to conclude that LPS-NC did not associate with stroke.
format Online
Article
Text
id pubmed-7034831
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-70348312020-02-27 Serum lipopolysaccharide neutralizing capacity in ischemic stroke Leskelä, Jaakko Pietiäinen, Milla Safer, Anton Lehto, Markku Metso, Jari Malle, Ernst Buggle, Florian Becher, Heiko Sundvall, Jouko Grau, Armin J. Pussinen, Pirkko J. Palm, Frederick PLoS One Research Article INTRODUCTION: Periodontitis is associated with increased serum lipopolysaccharide (LPS) activity, which may be one mechanism linking periodontitis with the risk of cardiovascular diseases. As LPS-carrying proteins including lipoproteins modify LPS-activity, we investigated the determinants of serum LPS-neutralizing capacity (LPS-NC) in ischemic stroke. The association of LPS-NC and Aggregatibacter actinomycetemcomitans, a major microbial biomarker in periodontitis, was also investigated. MATERIALS AND METHODS: The assay to measure LPS-NC was set up by spiking serum samples with E. coli LPS. The LPS-NC, LPS-binding protein (LBP), soluble CD14 (sCD14), lipoprotein profiles, apo(lipoprotein) A-I, apoB, and phospholipid transfer protein (PLTP) activity, were determined in 98 ischemic stroke patients and 100 age- and sex-matched controls. Serum and saliva immune response to A. actinomycetemcomitans, its concentration in saliva, and serotype-distribution were examined. RESULTS: LPS-NC values ranged between 51–83% in the whole population. Although several of the LPS-NC determinants differed significantly between cases and controls (PLTP, sCD14, apoA-I, HDL-cholesterol), the levels did not (p = 0.056). The main determinants of LPS-NC were i) triglycerides (β = -0.68, p<0.001), and ii) HDL cholesterol (0.260, <0.001), LDL cholesterol (-0.265, <0.001), PLTP (-0.196, 0.011), and IgG against A. actinomycetemcomitans (0.174, 0.011). Saliva A. actinomycetemcomitans concentration was higher [log mean (95% CI), 4.39 (2.35–8.19) vs. 10.7 (5.45–21) genomes/ml, p = 0.023) and serotype D more frequent (4 vs. 0%, p = 0.043) in cases than controls. Serotypeablity or serotypes did not, however, relate to the LPS-NC. CONCLUSION: Serum LPS-NC comprised low PLTP-activity, triglyceride and LDL cholesterol concentrations, as well as high HDL cholesterol and IgG against A. actinomycetemcomitans. The present findings let us to conclude that LPS-NC did not associate with stroke. Public Library of Science 2020-02-21 /pmc/articles/PMC7034831/ /pubmed/32084157 http://dx.doi.org/10.1371/journal.pone.0228806 Text en © 2020 Leskelä et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Leskelä, Jaakko
Pietiäinen, Milla
Safer, Anton
Lehto, Markku
Metso, Jari
Malle, Ernst
Buggle, Florian
Becher, Heiko
Sundvall, Jouko
Grau, Armin J.
Pussinen, Pirkko J.
Palm, Frederick
Serum lipopolysaccharide neutralizing capacity in ischemic stroke
title Serum lipopolysaccharide neutralizing capacity in ischemic stroke
title_full Serum lipopolysaccharide neutralizing capacity in ischemic stroke
title_fullStr Serum lipopolysaccharide neutralizing capacity in ischemic stroke
title_full_unstemmed Serum lipopolysaccharide neutralizing capacity in ischemic stroke
title_short Serum lipopolysaccharide neutralizing capacity in ischemic stroke
title_sort serum lipopolysaccharide neutralizing capacity in ischemic stroke
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7034831/
https://www.ncbi.nlm.nih.gov/pubmed/32084157
http://dx.doi.org/10.1371/journal.pone.0228806
work_keys_str_mv AT leskelajaakko serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT pietiainenmilla serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT saferanton serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT lehtomarkku serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT metsojari serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT malleernst serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT buggleflorian serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT becherheiko serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT sundvalljouko serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT grauarminj serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT pussinenpirkkoj serumlipopolysaccharideneutralizingcapacityinischemicstroke
AT palmfrederick serumlipopolysaccharideneutralizingcapacityinischemicstroke